Risultati della ricerca - Müller Dj
- Mostra 1 - 7 risultati su 7
-
1
Pharmacogenetics of antipsychotic treatment response and side effects di Mackenzie, B, Souza, RP, Likhodi, O, Tiwari, AK, Zai, CC, Sturgess, J, Müller, DJ
Pubblicazione 2010testo -
2
Clinical pharmacogenetics implementation consortium guideline (CPIC) for <i>CYP2D6</i> and <i>CYP2C19</i> genotypes and dosing of tricyclic antidepressants: 2016 update di JK Hicks, Katrin Sangkuhl, JJ Swen, VL Ellingrod, Müller Dj, Kazutaka Shimoda, JR Bishop, E D Kharasch, TC Skaar, Andrea Gaedigk, Henry M. Dunnenberger, Teri E. Klein, KE Caudle, Julia Stingl
Pubblicazione 2016Artigo -
3
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors di Hicks, JK, Bishop, JR, Sangkuhl, K, Müller, DJ, Ji, Y, Leckband, SG, Leeder, JS, Graham, RL, Chiulli, DL, LLerena, A, Skaar, TC, Scott, SA, Stingl, JC, Klein, TE, Caudle, KE, Gaedigk, A
Pubblicazione 2015testo -
4
Getting to Precision Psychopharmacology: Combining Clinical and Genetic Information to Predict Fat Gain from Aripiprazole di Oughli, H., Lenze, E.J., Locke, A.E., Yingling, M.D., Zhong, Y., Miller, J.P., Reynolds, C.F., Mulsant, B.H., Newcomer, J. W., Peterson, T.R., Müller, D.J., Nicol, G.E.
Pubblicazione 2019testo -
5
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and <i>CYP2C19</i> Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors di J K Hicks, JR Bishop, Katrin Sangkuhl, Müller Dj, Yuan Ji, SG Leckband, JS Leeder, RL Graham, DL Chiulli, Adrián LLerena, TC Skaar, Stuart A. Scott, Julia Stingl, Teri E. Klein, KE Caudle, Andrea Gaedigk
Pubblicazione 2015Artigo -
6
The nucleus acts as a ruler tailoring cell responses to spatial constraints di Lomakin, A.J., Cattin, C.J., Cuvelier, D., Alraies, Z., Molina, M., Nader, G.P.F., Srivastava, N., Saez, P.J., Garcia-Arcos, J.M., Zhitnyak, I.Y., Bhargava, A., Driscoll, M.K., Welf, E.S., Fiolka, R., Petrie, R.J., De Silva, N.S., González-Granado, J.M., Manel, N., Lennon-Duménil, A.M., Müller, D.J., Piel, M.
Pubblicazione 2020testo -
7
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting di LV Kalman, José A. G. Agúndez, Malin Lindqvist Appell, J.H. Black, GC Bell, Sotiria Boukouvala, Carsten Bruckner, Elspeth A. Bruford, KE Caudle, SA Coulthard, Ann K. Daly, AL Del Tredici, Johan T. den Dunnen, Katarzyna Drozda, Robin E. Everts, David A. Flockhart, Robert R. Freimuth, Andrea Gaedigk, Houda Hachad, Toinette Hartshorne, Magnus Ingelman‐Sundberg, Teri E. Klein, Volker M. Lauschke, DR Maglott, HL McLeod, GA McMillin, Meyer Ua, Müller Dj, D. A. Nickerson, WS Oetting, MA Pacanowski, Pratt Vm, MV Relling, Angharad M. Roberts, Rubinstein Ws, Katrin Sangkuhl, Matthias Schwab, Stuart A. Scott, SC Sim, RK Thirumaran, LH Toji, Rachel F. Tyndale, RHN van Schaik, Michelle Whirl‐Carrillo, K. L. B. Yeo, UM Zanger
Pubblicazione 2015Revisão
Strumenti per la ricerca:
Soggetti correlati
Biology
Gene
Genotype
Medicine
Pharmacogenetics
CYP2C19
CYP2D6
Cytochrome P450
Dosing
Genetics
Internal medicine
Metabolism
Pharmacology
Antidepressant
Anxiety
Biochemistry
Botany
Chemical nomenclature
Chemistry
Citalopram
Computational biology
Computer network
Computer science
Computer security
Confusion
Escitalopram
Fluoxetine
Fluvoxamine
Guideline
Nomenclature